Cargando…

Use of imaging modalities for decision-making in inflammatory bowel disease

Cross-sectional magnetic resonance enterography (MRE) and intestinal ultrasonography (IUS) provide valuable and noninvasive information to accurately assess disease activity, severity, and extent; detect complications; and monitor the response to treatment, as well as predict the postoperative recur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nancey, Stéphane, Fumery, Mathurin, Faure, Mathias, Boschetti, Gilles, Gay, Claire, Milot, Laurent, Roblin, Xavier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912556/ https://www.ncbi.nlm.nih.gov/pubmed/36777362 http://dx.doi.org/10.1177/17562848231151293

Ejemplares similares

Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease
por: Buisson, Anthony, et al.
Publicado: (2021)

Inflammatory bowel disease: towards a personalized medicine
por: Flamant, Mathurin, et al.
Publicado: (2018)

Regulation of anti-microbial autophagy by factors of the complement system
por: Viret, Christophe, et al.
Publicado: (2020)

Development of Antibodies to Ustekinumab Is Associated with Loss of Response in Patients with Inflammatory Bowel Disease
por: Roblin, Xavier, et al.
Publicado: (2023)

Inflammatory Bowel Disease and the SARS-CoV-2 Pandemic: More Speed, Less Haste
por: Gower-Rousseau, Corinne, et al.
Publicado: (2021)

Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study
por: Bouhnik, Yoram, et al.
Publicado: (2018)

Faster and less invasive tools to identify patients with ileal colonization by adherent‐invasive E. coli in Crohn's disease
por: Buisson, Anthony, et al.
Publicado: (2021)

Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study
por: Rayer, Cassandra, et al.
Publicado: (2023)

Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study
por: Cassandra, Rayer, et al.
Publicado: (2022)

Relationships of circulating CD4(+) T cell subsets and cytokines with the risk of relapse in patients with Crohn’s disease
por: Duclaux-Loras, Rémi, et al.
Publicado: (2022)

Golimumab for the treatment of ulcerative colitis
por: Flamant, Mathurin, et al.
Publicado: (2017)

Endoscopic submucosal resection with adaptative traction device: a new strategy to facilitate resection in patient with inflammatory bowel disease
por: Masgnaux, Louis-Jean, et al.
Publicado: (2023)

Iron Deficiency in Patients with Inflammatory Bowel Diseases: A Prospective Multicenter Cross-Sectional Study
por: Peyrin-Biroulet, Laurent, et al.
Publicado: (2022)

Budget impact analysis of the subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in the Big-5 European (E5) countries
por: Yoo, Hyun Kyeong, et al.
Publicado: (2022)

Fetal death in utero and miscarriage in a patient with Crohn’s disease under therapy with ustekinumab: case-report and review of the literature
por: Venturin, C., et al.
Publicado: (2017)

Shared decision-making in the management of patients with inflammatory bowel disease
por: Song, Kai, et al.
Publicado: (2022)

Shared Decision-Making for a Dialysis Modality
por: Yu, Xueqing, et al.
Publicado: (2021)

Gastroenterologists’ Views of Shared Decision Making for Patients with Inflammatory Bowel Disease
por: Siegel, Corey A., et al.
Publicado: (2015)

Utility of Intestinal Ultrasound in Clinical Decision-Making for Inflammatory Bowel Disease
por: Saleh, Adam, et al.
Publicado: (2023)

Therapeutic drug monitoring of vedolizumab in inflammatory bowel disease: current data and future directions
por: Ward, Mark G., et al.
Publicado: (2018)

Preferences Regarding Shared Decision-Making in Japanese Inflammatory Bowel Disease Patients
por: Morishige, Ryuji, et al.
Publicado: (2016)

Impact of Fecal Calprotectin Measurement on Decision-making in Children with Inflammatory Bowel Disease
por: El-Matary, Wael, et al.
Publicado: (2017)

Molecular Profiling of Inflammatory Bowel Disease: Is It Ready for Use in Clinical Decision-Making?
por: Lee, Ho-Su, et al.
Publicado: (2019)

Management of dental care of patients on immunosuppressive drugs for chronic immune-related inflammatory diseases: a survey of French dentists’ practices
por: Bourgoin, Alice, et al.
Publicado: (2023)

Shared decision making in pregnancy in inflammatory bowel disease: design of a patient orientated decision aid
por: Williams, Astrid-Jane, et al.
Publicado: (2021)

Cytomegalovirus and Inflammatory Bowel Diseases (IBD) with a Special Focus on the Link with Ulcerative Colitis (UC)
por: Jentzer, Alexandre, et al.
Publicado: (2020)

Commentary: Impact of Fecal Calprotectin Measurement on Decision-Making in Children with Inflammatory Bowel Disease
por: Day, Andrew S., et al.
Publicado: (2017)

Patients’ views of shared decision making in inflammatory bowel disease: a survey in China
por: Xu, Dingting, et al.
Publicado: (2021)

Choice of dialysis modality: patients’ experiences and quality of decision after shared decision-making
por: Finderup, Jeanette, et al.
Publicado: (2020)

Managing complex perianal disease after anti-TNF failure: Where to go next?
por: Yzet, Clare, et al.
Publicado: (2022)

Detection of inflammatory bowel disease: diagnostic performance of cross-sectional imaging modalities
por: Horsthuis, Karin, et al.
Publicado: (2007)

A Novel Decision Aid Improves Quality of Reproductive Decision-Making and Pregnancy Knowledge for Women with Inflammatory Bowel Disease
por: Wang, Grace, et al.
Publicado: (2022)

Factors affecting clinical decision-making in inflammatory bowel disease and the role of point-of-care calprotectin
por: Derwa, Yannick, et al.
Publicado: (2018)

Physicians Should Provide Shared Decision-Making for Anti-TNF Therapy to Inflammatory Bowel Disease Patients
por: Cha, Jae Myung, et al.
Publicado: (2017)

Decision Making in Patients With Metastatic Spine. The Role of Minimally Invasive Treatment Modalities
por: Conti, Alfredo, et al.
Publicado: (2019)

Alteration of microbiota antibody‐mediated immune selection contributes to dysbiosis in inflammatory bowel diseases
por: Michaud, Eva, et al.
Publicado: (2022)

The Kynurenine Pathway and Cancer: Why Keep It Simple When You Can Make It Complicated
por: Gouasmi, Roumaïssa, et al.
Publicado: (2022)

Evaluating treatment modalities in chronic pain treatment by the multi-criteria decision making procedure
por: Sir, Ender, et al.
Publicado: (2019)

A Clinical Decision-Making Framework for the Use of Video Gaming as a Therapeutic Modality
por: Espy, Debbie, et al.
Publicado: (2021)

Quality-checking the new normal: trial modality in online jury decision-making research
por: Maeder, Evelyn M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_slc95d4psms1i4pbufbkoppgm6